Research and Markets (http://www.researchandmarkets.com/research/m22thp/vancomycinresista)
has announced the addition of the "Vancomycin-Resistant
Enterococcus Faecium Infections - Pipeline Review, H1 2014"
report to their offering.
This report provides comprehensive information on the therapeutic
development for Vancomycin-Resistant Enterococcus Faecium Infections,
complete with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and
featured news and press releases. It also reviews key players involved
in the therapeutic development for Vancoycin-Resistant Enterococcus
Faecium Infections and special features on late-stage and discontinued
Drug profiles/records featured in the report undergoes periodic updation
following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally,
processes including live news & deals tracking, browser based alert-box
and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.
The report enhances decision making capabilities and help to create
effective counter strategies to gain competitive advantage. It
strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.
For more information visit http://www.researchandmarkets.com/research/m22thp/vancomycinresista
[ Back To NFVZone's Homepage ]